The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Korbel Gregory Alan since 2019.
This trader's CIK number is 1789032.
At the time of last reporting, Korbel Gregory Alan was the SVP, Chief Business Officer of Aprea Therapeutics, Inc.. (stock ticker symbol APRE).
Also see all insider trading activities at Aprea Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | APRE | 0 | $0 | 115,460 | $544,851 | 110,000 | $101,200 |
2019 | APRE | 500 | $7,500 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-12-01 | APRE | Sale | 27,500 | 3.96 | 108,900 |
2021-12-01 | APRE | Option Ex | 27,500 | .92 | 25,300 |
2021-11-01 | APRE | Option Ex | 27,500 | .92 | 25,300 |
2021-11-01 | APRE | Sale | 27,500 | 5.00 | 137,500 |
2021-10-01 | APRE | Sale | 27,500 | 4.89 | 134,475 |
2021-10-01 | APRE | Option Ex | 27,500 | .92 | 25,300 |
2021-09-20 | APRE | Sale | 32,960 | 4.97 | 163,976 |
2021-09-20 | APRE | Option Ex | 27,500 | .92 | 25,300 |
2019-10-07 | APRE | Buy | 500 | 15.00 | 7,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Korbel Gregory Alan (SVP, Chief Business Officer of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.